Low-dose oral minoxidil for pattern hair loss
Part of Skin clinical trials.
This trial tests a low-dose oral form of minoxidil (a hair growth medicine) for people with pattern hair loss. It aims to see if this treatment helps regrow hair in a convenient way.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with mild to severe male or female pattern hair loss (androgenetic alopecia).
- You have not used any hair loss treatments (pills or creams) in the last 3 months.
- You do not have other hair loss causes like hormonal issues, scarring or inflammatory hair loss, or extra male hormones.
- You are not allergic to minoxidil.
- You do not have serious health problems like heart, kidney, or liver disease, or high or low blood pressure.
- You are not pregnant or breastfeeding, and you are willing to give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral pill form of minoxidil, a common hair growth treatment, for men with male pattern baldness. It aims to see if the pill is safe and effective in helping hair regrow.
This trial tests if dihydroartemisinin, a medicine derived from a plant, can help treat female pattern hair loss. It may be an option for women who haven't used other hair loss treatments recently.
This trial tests whether a lotion containing a beneficial bacteria (Lactobacillus reuteri) can help with male or female pattern hair loss. The treatment is applied directly to the scalp.
This study tests a new investigational drug, OLX72021, given as injections into the scalp, to see if it can help regrow hair in men with male pattern baldness. It will also check how safe the drug is and how well it works.
This study compares a new peptide-based hair serum with minoxidil (a common hair-regrowth treatment) in people with androgenetic alopecia, a type of hair loss caused by genetics and hormones. The trial lasts 24 weeks and measures how well each treatment works.
This study tests a new scalp solution (KX-826) for men with androgenetic alopecia, commonly known as male pattern baldness. It aims to see if the solution can help regrow hair and is safe to use. Participants will apply the solution to their scalp and have their hair growth monitored over time.
Hear when a new Androgenetic Alopecia (AGA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.